Russia claims to have developed the world's first mRNA cancer vaccine.

Russia has announced the development of what it claims is the world's first mRNA cancer vaccine. According to officials in Moscow, the vaccine, named Enteromix, has demonstrated 100% efficacy in clinical trials by shrinking and destroying tumors without significant side effects.

This vaccine uses technology similar to that of COVID vaccines and is presented as a form of personalized immunotherapy. It is designed to help the body target cancer cells while leaving healthy tissue unharmed.

The clinical trials included various types of cancer, such as lung, breast, colorectal, pancreatic, and even those resistant to chemotherapy.

Enteromix is currently in limited clinical use in Russia and is awaiting final approval from the Health Ministry for broader distribution.

If the claimed results are confirmed, this could represent a significant advancement in medical science and have geopolitical implications. A cancer treatment backed by the Kremlin could be a notable point of discussion in international relations.

Source: Mario Nawfal, @Osint613, Rising Kashmir, WION, @BRICSinfo